Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol vs Maxacalcitol in CKD with Secondary Hyperparathyroidism
NCT00990704Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Oct 2009
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Abbott Laboratories. Started Oct 2009; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00990704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990704.